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Review Article
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Abstract: As a result of the rapid acceleration in new treatment advances in thoracic oncology,
coordination and tailored selection of treatment modalities has become complex. This increasing complexity
mandates multidisciplinary input and coordinated management. However, quality of care in the domain
of multidisciplinary thoracic oncology has yet to be purposefully defined, and as a result the science of
performance measurement has yet to be applied to this area. In this review we discuss the role of multidisciplinary care in thoracic oncology, and outline its definitions as proposed in the literature. We review
various metrics of quality in complex multidisciplinary thoracic oncology care, and future directions for
quality and performance measurement.
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Introduction
While there has been an undeniable acceleration of
advances in thoracic oncology in the fields of surgery,
radiation oncology, and medical oncology, coordination
and tailored selection of treatment modalities has become
increasingly complex. As more therapeutic options become
available, the standard-of-care for early stage, locally
advanced, and metastatic lung, esophageal, and pleural
malignancies is continually evolving. This ongoing state
of change requires the development of robust, multidisciplinary care approaches to facilitate effective, often
individually tailored, treatment plans.
While increasing complexity in both disease presentation
and therapeutic options mandate multidisciplinary input,
time pressures on clinicians required to provide such
care have also increased (1). Hence, it is imperative to
ensure that these processes are as effective and efficient as
possible. Complex, multidisciplinary oncology care—like
that required for the treatment of thoracic malignancies is
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an area in which quality of care has yet to be purposefully
defined and thoroughly measured. Performance
measurement is a burgeoning area within healthcare in
general, but implementing measurement principles in this
domain is a particular challenge because much of thoracic
oncology care requires precise coordination of complex
care from multiple specialties and which spans the range
of curative to palliative care. Here, we discuss the role
of multi-disciplinary thoracic oncologic care, metrics of
quality, and future directions.
What is multidisciplinary care?
Multidisciplinary care is commonly understood to represent
a model of healthcare delivery which is comprised of
coordinated care delivered by groups of appropriate
specialists. Multidisciplinary teams in thoracic malignancies,
typically include thoracic surgeons, radiation oncologists,
pathologists, thoracic radiologists, medical oncologists,
and palliative care specialists. This paradigm of care is
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widely advocated by professional groups and supported in
clinical guidelines (2). Similarly, patient advocacy efforts
also frequently focus on promoting multidisciplinary
care as a counterweight to the variability and uncertainty
in care decisions often encountered by patients. This is
especially true for those patients with rare cancers such as
advanced thymoma or mesothelioma. However, the discrete
operational characteristics of multidisciplinary care delivery
are only vaguely described in the literature.
The classic example of multidisciplinary care is the
tumor board meeting, in which physicians of representative
specialties discuss cases requiring complex management.
Typically, cases are presented and a consensus management
plan arrived upon as a result of the discussion by the
physicians in attendance. The value of these groups has
been most discretely measured in terms of changes made
to patient diagnostic or therapeutic management plans (3).
While these tumor boards certainly do add value in
these tangible domains, they may also aid in clinical trial
consideration and recruitment (4). This is not necessarily
limited to the academic environment, as community
hospital tumor boards frequently serve as the mechanism to
facilitate referral to tertiary or quaternary care centers.
Defining the quality of multidisciplinary care
Defining quality in complex thoracic oncology care is an
open question. What, precisely, does quality care look
like, and from whose perspective? For the purposes of this
article, we will focus on specific measurement strategies
and techniques for performance measurement that may
be applicable to the measurement of the care delivered by
teams treating patients with thoracic malignancy.
The first task in measuring the quality of
multidisciplinary care is to define it. Osarogiagbon
proposes 4 key factors that must be present to meet the
definition of multidisciplinary care: the clinical interaction
must be prospective, so that opportunity remains for the
interdisciplinary engagement to influence the care and
outcomes of the individual patient; key members of the
thoracic oncology care delivery team must be engaged;
accurate data must be presented and reviewed; and a robust
framework for communication must be established (2,5).
With these 4 key factors defined, the structure of the
actual care delivery environment can vary based upon
the local context in which care is delivered. For example,
whether clinicians of various specialties interact with
patients in a co-located clinic, by conference without direct
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patient involvement, or virtually, is less important. Granular
aspects of the function of the multidisciplinary team
(MDT) can then be measured—for example, measurement
of tumor board performance via a basic checklist to
ensure that essential personnel are present and the critical
elements of the history, pathology and radiology studies
are available for review. The incorporation of all relevant
patient information in the MDT discussion is a particular
strength of this multidisciplinary approach to care,
allowing for individualization of treatment decisions. For
example, the presence of comorbid conditions frequently
influences treatment recommendations (6). Hence, accurate
information regarding all aspects of the patient’s medical
history, not merely focused information regarding the
oncologic problem are necessary for the MDT to make
appropriate treatment recommendations.
Measuring quality
With the framework of multidisciplinary care defined, the
focus next shifts to determining how to measure the quality
and performance of these functional units. Benchmarking,
whereby multidisciplinary units of similar constitution
and function are compared, has yet to be applied to the
assessment of multi-disciplinary care. Single specialty efforts
to benchmark outcomes, by contrast, are well developed in
thoracic surgery, especially for short-term surgical outcomes
such as 30-day mortality (7).
Efforts to directly measure multi-disciplinary care have
to this point been lacking. Most studies of the process
and outcomes effects of multidisciplinary care have
been retrospective; either non-comparative or pre-post
intervention studies. Process outcomes, such as timeliness
of care, or utilization of appropriate staging modalities, have
dominated ‘hard’ outcomes such as survival, presumably
due to their relative ease of capture and short-term
measurement in retrospective data. Further, some authors
question the applicability of survival as an appropriate
outcome, especially for palliative patient populations.
Studies of tumor boards, by contrast, have focused on their
impact in increasing utilization of guideline concordant
care (3,6,8-10). Indeed, the proportion of treatment
decision changes made as a result of multidisciplinary
review has been proposed as a quality metric. Vinod and
colleagues found that guideline concordance with respect
to the recommendations concerning surgery, radiation
and chemotherapy only approached 70% on average, with
recommendations for surgery where guidelines would
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recommend it in only 60% of examined cases. Deviations
largely arose as a result of advanced patient age, comorbidity
and performance status (9). Patient-centered outcomes, which
are as important, if not more so in patients with cancer, are
also largely unstudied in thoracic oncology. One preliminary
qualitative study has shown high satisfaction with clinic
co-location of services for lung cancer patients (11).
One approach to analyzing and measuring the quality
of multi-disciplinary thoracic oncology care is to break
the care elements down into the specialty blocks which
comprise the care team. For example, surgical resection
rates for early stage disease, or the proportion of patients
undergoing lymph node staging have been suggested as
possible endpoints (2). While a great deal of progress
has been made in the measurement of surgical quality in
isolation, measurement of quality in other domains of
thoracic oncology, such as radiation, medical oncology and
palliative care are less well defined. Even within specialties
such as surgery where outcomes and quality have been
studied extensively, they have largely been limited to broad
perioperative domains such as mortality, complications
and readmissions (7). While certainly more feasible,
measuring the quality of one domain in isolation gives
a narrow picture of the breadth of care that is provided
by multidisciplinary teams. Far more complex is the
measurement of the interaction between specialists and
the function of multidisciplinary cancer conferences in
assuring guideline-concordant and high quality care (3).
Some initial attempts to measure these interactions have
demonstrated potentially meaningful gaps in quality.
Rajaram and colleagues found significant underutilization
of adjuvant chemotherapy following surgical resection in
a national study (12). Credentialing groups such as the
Commission on Cancer have incorporated quality measures
into the review paradigm for programs, but the areas that
perform most poorly related to the transition of care from
one specialist to another (13). These interactions are what we
believe provide for the best care in complex cases, and yet their
outcomes remain nebulous. Overall survival seems an obvious
starting point, but even then, it only applies to the fraction of
patients treated curatively and misses a large proportion of care
provided by all specialties dealing with thoracic cancers, many
of which are done within a palliative framework.
Future directions of multidisciplinary care
While the landscape of multidisciplinary care has certainly
evolved in the last decade, the current era in thoracic
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oncology demands perhaps the greatest level of integration.
The advent of immunotherapy, improvements in radiation
techniques, and developments in the safety and efficacy of
surgery have thrown into question traditional treatment
paradigms and created many areas of uncertainty.
Virtual tumor boards may aid in extending the benefits
of multidisciplinary care for these situations to patients
in remote areas (14), while “mini tumor boards” have
been proposed for patients in low- and middle-income
countries (10). Clearly, patient-centered outcomes such as
quality of life and satisfaction are an area in need of greater
attention and research, and what impact multidisciplinary
care has on these important measures of healthcare
efficiency and efficacy must be investigated. Demonstrating
the utility of multidisciplinary care in terms of increased
efficiency, or timeliness of care, may help to motivate the
uptake of the multidisciplinary approaches, building on
the work of Osarogiagbon and colleagues, particularly
for the idea of co-located clinics (2). One of the main
questions that future studies will need to answer is the
relative effectiveness of clinic co-location, which has the
advantage of multidisciplinary input while the patient is
being evaluated, versus organ-specific tumor boards which
occur after the individual evaluations have taken place.
Lastly, while these tumor boards are clearly important on
an individual level, the impact of multi-disciplinary models
on a population-level has not been evaluated, but is likely
significant. Measuring the benefits of these approaches,
while challenging, is key to engaging clinicians in a way that
is relevant to their clinical practice.
Conclusions
In an era of rapid changes in thoracic oncology, clinician
engagement in multidisciplinary care is more important
than ever. Although the concept of measuring the function
of multidisciplinary groups is intrinsically appealing,
the definition, structure and relevant outcomes for such
groups remain largely undefined. Despite the challenges,
however, progress is being made especially with respect to
the development of relevant patient-centered outcomes,
which are critical for the measurement of care quality
in the majority of advanced staged lung cancer patients.
While measurement of impact remains a challenge,
multidisciplinary care represents a platform for quality
improvement and knowledge translation that is more
critical than ever in the complex and evolving field of
thoracic oncology.
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